For men with intermediate risk prostate cancer, side effects at two years following radiation therapy (RT) were comparable for extremely - hypofractionated treatment, which was delivered in seven fractions across two and a half weeks, and conventional treatment of 39 fractions across eight weeks, according to research presented at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO). (sciencedaily.com)
Researchers found that the one - month duration HRT, was associated with a significant improvement in recurrence compared to the two - month duration CRT and therefore would be reasonable to consider in men with intermediate risk prostate cancer and who do not have risk factors that could predispose the patient to bladder side effects several years after the treatment is complete. (sciencedaily.com)
Use of an accelerated chest pain assessment protocol in patients at intermediate risk of adverse cardiac events (cambridge.org)